Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

Author:

Wu Yi-Long,Cheng Ying,Zhou Jianying,Lu Shun,Zhang Yiping,Zhao Jun,Kim Dong-Wan,Soo Ross Andrew,Kim Sang-We,Pan Hongming,Chen Yuh-Min,Chian Chih-Feng,Liu Xiaoqing,Tan Daniel Shao Weng,Bruns Rolf,Straub Josef,Johne Andreas,Scheele Jürgen,Park Keunchil,Yang James Chih-Hsin,Wu Yi-Long,Liu Xiaoqing,Liu Zhe,Lu Shun,Chen Xi,Pan Hongming,Wang Mengzhao,Yu Shiying,Zhang Helong,Zhang Yiping,Fang Jian,Li Wei,Zhou Jianying,Zhao Jun,Cheng Ying,Yang Chih-Hsin,Chang Gee-Chen,Chen Yuh-Min,Hsia Te-Chun,Chian Chih-Feng,Yang Cheng-Ta,Wang Chin-Chou,Kim Sang-We,Park Keunchil,Kim Dong-Wan,Cho Byoung Chul,Lee Ki Hyeong,Kim Young-Chul,An Ho Jung,Woo In Sook,Cho Jae Yong,Shin Sang Won,Lee Jong-Seok,Kim Joo-Hang,Yoo Seung Soo,Kato Terufumi,Shinagawa Naofumi,Soo Ross Andrew,Tan Shao Weng Daniel,Ngo Lynette Si-Mien,Ratnavelu Kananathan,Ahmad Azura Rozila,Liam Chong Kin,de Marinis Filippo,Tassone Pierfrancesco,Molla Amelia Insa,Calles Blanco Antonio,Lazaro Quintela Martin Emilio,Felip Font Enriqueta,Dingemans Anne-Marie,Bui Lynne

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3